Pfizer Inc. and BioNTech SE today announced the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application for the companies' LP.8.1-adapted monovalent COVID-19 vaccine (COMIRNATY® LP.8.1; COVID-19 Vaccine, mRNA) for use in adults aged 65 years and older.
UK Wastewater Testing to Reveal Dangerous Pathogens
A new program in the United Kingdom will evaluate how wastewater monitoring could be used to detect a broader range of dangerous pathogens.
Announced by the UK Health Security Agency (UKHSA) on August 26, 2025, using £1.3 million of investment from the UK Integrated Security Fund, the project will assess the use of cutting-edge technologies to improve the UK's ability to detect and identify the genetic material of various viruses in wastewater, tracking how the amount of virus detected changes over time.
Brief Mindset Intervention Can Reduce Depression, Inflammation
Changes in mindset mediated effects of intervention on posttraumatic growth, depression symptoms, other domains of mental health